EPISODE · May 1, 2025 · 14 MIN
Zurich based CUTISS is developing a personalized tissue therapy that enables on-demand production of living skin for surgeries
from BiotechTV - News · host BiotechTV
Co-Founder & CEO Daniela Marino describes why CUTISS believes denovoSKIN is superior to autografting. She describes how they make it, walks us through the company's on-site GMP facility, and she discusses the clinical experience to date. The therapy is already in a phase 3 study in Europe.
What this episode covers
Co-Founder & CEO Daniela Marino describes why CUTISS believes denovoSKIN is superior to autografting. She describes how they make it, walks us through the company's on-site GMP facility, and she discusses the clinical experience to date. The therapy is already in a phase 3 study in Europe.
NOW PLAYING
Zurich based CUTISS is developing a personalized tissue therapy that enables on-demand production of living skin for surgeries
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m